Abstract: Poster Presentations |

Use of Real-World Experience Data in Patients Treated With Formoterol Fumarate Inhalation Powder FREE TO VIEW

C P. Fuhrmann, MD, FCCP; D Paradis, MBA
Author and Funding Information

Private Practice, Kennebunk, ME


Chest. 2003;124(4_MeetingAbstracts):141S. doi:10.1378/chest.124.4_MeetingAbstracts.141S-a
Text Size: A A A
Published online


PURPOSE:  Provider-patient communication is critical to appropriate and effective health care management. This study describes a program that communicated to providers direct-from-patient experiences with formoterol fumarate inhalation powder in the treatment of breathing difficulties associated with asthma, chronic obstructive pulmonary disease (COPD), or exercise-induced bronchospasm (EIB).

METHODS:  Physicians provide eligible patients with program materials and patients consent to completing two surveys—prior to using formoterol fumarate inhalation powder and after at least seven days of use. Surveys collect patient experiences with the medication and the device in relation to their breathing condition. Survey results are summarized for each patient and sent to the prescribing physician.

RESULTS:  190 patients have enrolled in this ongoing program; 94 completed both surveys as of April 22, 2003. Average age was 62 years, and 68% were female. 43% indicated asthma as their breathing condition, followed by COPD (38%). 83% indicated their provider showed them how to use the device and 67% reported the medication delivery device was easy to use. After use of formoterol fumarate inhalation powder, patients indicated breathing difficulties interfered less with general daily activities (37%), leisure activities (41%), and overall enjoyment of life (40%). 72% indicated intent to continue using formoterol fumarate inhalation powder. Patients reported their primary motivation for participating was a request from their physician (50%) or a desire to provide information to their physician (30%).CONCLUSIONS: With formoterol fumarate inhalation powder, patients reported less interference from their breathing condition and that the medication delivery device was easy to use. This study describes a practical approach to provide physicians with self-reported information from their own patients regarding patients’ experiences with therapy.

CLINICAL IMPLICATIONS:  Patient self-reported data can be combined with other patient data to help physicians make necessary decisions for the effective health care management and education of their patients.

DISCLOSURE:  C.P. Fuhrmann, InfoMedics, Inc.; presenter and participating physician in the study; FRN0014 5/03

Wednesday, October 29, 2003

12:30 PM - 2:00 PM




Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543